Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jul-Dec;8(2):70-76.
doi: 10.4103/2229-5070.248695. Epub 2018 Dec 27.

Drug susceptibility testing methods of antimalarial agents

Affiliations
Review

Drug susceptibility testing methods of antimalarial agents

Ardhendu K Maji. Trop Parasitol. 2018 Jul-Dec.

Abstract

Resistance to almost all available antimalarial agents, particularly for Plasmodium falciparum, is an important issue throughout all malaria endemic countries. Recently, Plasmodium vivax also showed resistance to chloroquine in some part of the World. Monitoring efficacy of used antimalarial drugs plays an important role to determine the emergence of resistant power by the prevailing parasite population of a geographical area if any. There are four different methods for antimalarial drug efficacy study. In vivo therapeutic efficacy study remains the gold standard and provides primary data for formulating antimalarial drug policy by the National Malaria Control Programmes. Several in vitro assay methods for assessing antimalarial drug susceptibility have been developed during past few decades. These assay methods are simple, easier to handle and allow early detection of drug-resistant parasites and also for the screening of different newly developed agents for their antimalarial activity. Approaches of different assay methods for testing the susceptibility of antimalarial agents and their limitations are discussed in this review article.

Keywords: Antimalarial agents; Plasmodium falciparum; drug susceptibility assay; in vitro culture methods.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Similar articles

Cited by

References

    1. World Health Organization. World Malaria Report: 2015. Geneva, Switzerland: World Health Organization; 2015.
    1. World Health Organization. Global Technical Strategy for Malaria 2016-2030. Geneva, Switzerland: World Health Organization; 2015.
    1. Miotto O, Almagro-Garcia J, Manske M, Macinnis B, Campino S, Rockett KA, et al. Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia. Nat Genet. 2013;45:648–55. - PMC - PubMed
    1. Kasturi K, Mallika DS, Amos SJ, Venkateshaiah P, Rao KS. Current opinion on an emergence of drug resistant strains of Plasmodium falciparum through genetic alterations. Bioinformation. 2012;8:1114–8. - PMC - PubMed
    1. Vinayak S, Biswas S, Dev V, Kumar A, Ansari MA, Sharma YD. Prevalence of the K76T mutation in the pfcrt gene of Plasmodium falciparum among chloroquine responders in India. Acta Trop. 2003;87:287–93. - PubMed